phloroglucinol has been researched along with HIV in 3 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four phloroglucinol derivatives, named mallotophenone (5-methylene-bis-2,6-dihydroxy-3-methyl-4-methoxyacetophenone), mallotochromene (8-acetyl-5,7-dihydroxy-6-(3-acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-2,2-dimethylchromene), mallotojaponin (3-(3,3(dimethylallyl)5-(3(acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-phloracetophenone) and mallotolerin (3-(3-methyl-2-hydroxybut-3-enyl)-5(3-acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-phloracetophenone), have been tested for their ability to inhibit the activity of human immunodeficiency virus (HIV)-reverse transcriptase." | 7.68 | Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. ( Arisawa, M; Fujita, A; Koshimura, S; Nakane, H; Ono, K, 1991) |
| "Four phloroglucinol derivatives, named mallotophenone (5-methylene-bis-2,6-dihydroxy-3-methyl-4-methoxyacetophenone), mallotochromene (8-acetyl-5,7-dihydroxy-6-(3-acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-2,2-dimethylchromene), mallotojaponin (3-(3,3(dimethylallyl)5-(3(acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-phloracetophenone) and mallotolerin (3-(3-methyl-2-hydroxybut-3-enyl)-5(3-acetyl-2,4- dihydroxy-5-methyl-6-methoxybenzyl)-phloracetophenone), have been tested for their ability to inhibit the activity of human immunodeficiency virus (HIV)-reverse transcriptase." | 3.68 | Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. ( Arisawa, M; Fujita, A; Koshimura, S; Nakane, H; Ono, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vo, TS | 1 |
| Kim, SK | 1 |
| Ghisalberti, EL | 1 |
| Nakane, H | 1 |
| Arisawa, M | 1 |
| Fujita, A | 1 |
| Koshimura, S | 1 |
| Ono, K | 1 |
2 reviews available for phloroglucinol and HIV
| Article | Year |
|---|---|
Potential anti-HIV agents from marine resources: an overview.
Topics: Animals; Anti-HIV Agents; Aquatic Organisms; Biological Products; Chitin; Drug Resistance, Viral; HI | 2010 |
Bioactive acylphloroglucinol derivatives from Eucalyptus species.
Topics: Aldehyde Reductase; Anti-Bacterial Agents; Anti-Infective Agents; Diabetic Retinopathy; Eucalyptus; | 1996 |
1 other study available for phloroglucinol and HIV
| Article | Year |
|---|---|
Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives.
Topics: Base Sequence; DNA; HIV; Molecular Sequence Data; Molecular Structure; Phloroglucinol; Plants; Rever | 1991 |